EGFR and neoplasm: Palmitoylation is essential for the function of both oncogenes (e.g., HRAS, NRAS, and epidermal growth factor receptor [EGFR]) and tumour suppressors (e.g., SCRIB, melanocortin 1 receptor) [145,146].